Eurobio Scientific S.A.
ALERS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | €3,998 | €4,835 | €24,937 | €60,544 |
| Dep. & Amort. | €17,054 | €13,145 | €9,225 | €7,865 |
| Deferred Tax | €0 | €0 | €1,320 | €1,641 |
| Stock-Based Comp. | €0 | €0 | €0 | €0 |
| Change in WC | -€4,298 | €8,345 | €8,842 | -€3,665 |
| Other Non-Cash | -€51 | €442 | -€1,251 | -€469 |
| Operating Cash Flow | €16,703 | €26,767 | €41,848 | €65,461 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€3,256 | -€4,054 | -€2,834 | -€1,847 |
| Net Acquisitions | -€10,121 | -€4,502 | -€129,639 | €100 |
| Inv. Purchases | €0 | €0 | -€9,283 | -€3,724 |
| Inv. Sales/Matur. | €0 | €0 | €138,922 | €0 |
| Other Inv. Act. | €2,637 | €8,238 | -€138,922 | €1 |
| Investing Cash Flow | -€10,740 | -€318 | -€141,756 | -€5,470 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€90,909 | -€18,204 | €97,360 | -€14,224 |
| Stock Issued | €0 | €0 | €0 | €0 |
| Stock Repurch. | -€149 | -€2,792 | -€12,238 | -€6,909 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €18,972 | -€2,507 | -€2,813 | -€2,622 |
| Financing Cash Flow | -€72,086 | -€23,503 | €82,309 | -€23,755 |
| Forex Effect | €159 | €147 | -€77 | €138 |
| Net Chg. in Cash | -€65,963 | €3,093 | -€16,451 | €36,829 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €89,028 | €85,935 | €92,919 | €65,101 |
| End Cash | €23,065 | €89,028 | €47,493 | €92,919 |
| Free Cash Flow | €13,447 | €22,713 | €39,014 | €63,614 |